By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on ...

The IPO had raised 35.7 billion Hong Kong dollars ($4.6 billion) according to a company filing, reportedly making it the ...

Shares of Contemporary Amperex Technology Co., or CATL, soared more than 16% in their Hong Kong trading debut Tuesday after ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Shares of the company, CATL, surged in their first day of trading. Onshore U.S. investors were blocked from buying its stock ...

Shares in CATL closed 16% higher on their Hong Kong debut on Tuesday after the Chinese electric vehicle battery giant raised ...

Shares of Chinese companies Jiangsu Hengrui Pharmaceuticals and Mirxes Holdings rose sharply on Friday in Hong Kong trading debuts after raising a combined $1.4 billion in separate listings.

Delisting worries have grown since late February, when President Donald Trump revived the threat of kicking Chinese companies off U.S. exchanges.

CATL, which produces more than a third of all electric vehicle batteries sold worldwide, raised US$4.6 billion in Hong Kong.

Contemporary Amperex Technology Co. Ltd., or CATL, controls more than a third of the global market for EV batteries and is ...

Chinese battery manufacturer CATL aims to raise at least HK$31.01 billion ($3.99 billion) in its Hong Kong listing, according ...